Company Organovo Holdings Inc Nyse
Equities
US68620A1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
3D Human Tissue Platform
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -75.33% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -75.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Keith Murphy
CEO | Chief Executive Officer | 52 | 31/12/06 |
Thomas Hess
DFI | Director of Finance/CFO | 60 | 30/09/21 |
Steve Kunszabo
IRC | Investor Relations Contact | - | - |
Curtis Tyree
PRN | Corporate Officer/Principal | - | 17/02/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Stern
BRD | Director/Board Member | 60 | 31/01/12 |
Keith Murphy
CEO | Chief Executive Officer | 52 | 31/12/06 |
David Gobel
BRD | Director/Board Member | 71 | 14/09/20 |
Douglas Cohen
BRD | Director/Board Member | 53 | 14/09/20 |
Alison Milhous
BRD | Director/Board Member | 45 | 14/09/20 |
Vaidehi Joshi
BRD | Director/Board Member | 38 | 07/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,040,120 | 9,848,719 ( 98.09 %) | 46 ( 0.000458 %) | 98.09 % |
Company contact information
Organovo Holdings, Inc.
11555 Sorrento Valley Road Suite 100
92121, San Diego
+(858) 224-1000
http://www.organovo.comSector
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.51% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- ONVO Stock
- Stock
- Company Organovo Holdings Inc